Moreover, among stage I GC patients who did not receive concurrent adjuvant chemotherapy according to the ACRG dataset, we noted that 8 H. pylori+ GC patients displayed abundant CAF infiltration compared to 7 H. pylori− GC patients, as evidenced by α‐SMA expression (Figure 1B). This evidence concerns the gene ACTA1 and gastric cancer.